Types of DOT Drug and Alcohol Tests and Their Compliance Benefits

What are the urine drug test types required by DOT?

Urine drug tests are the primary method mandated by the Department of Transportation (DOT) for safety-sensitive employees. The standard DOT urine drug screen detects five drug classes: marijuana (THC), cocaine, opiates (codeine, morphine, heroin), amphetamines (including methamphetamine), and phencyclidine (PCP).

Testing follows the federally certified urine protocol under 49 CFR Part 40, which specifies collection procedures, specimen handling, and cutoff concentrations to ensure accuracy and chain of custody. Cutoff levels for initial testing include 50 ng/mL for marijuana metabolite and 150 ng/mL for cocaine metabolite. Confirmatory GC-MS or LC-MS/MS testing applies more stringent thresholds.

These tests have detection windows ranging from 1 to 4 days depending on the drug and individual metabolism. The five-panel DOT drug test is standard for pre-employment, random, reasonable suspicion, post-accident, return-to-duty, and follow-up testing.

What types of alcohol tests comply with DOT testing requirements?

DOT alcohol testing mandates use of evidential breath testing devices (EBTs) approved by the National Highway Traffic Safety Administration (NHTSA) for screening and confirmation. The breath test measures blood alcohol concentration (BAC) via alveolar breath samples.

A screening test must register a BAC below 0.02 to be negative. Confirmatory breath tests are required if the initial screen is 0.02 or higher. The DOT cutoff for alcohol positivity is a BAC of 0.04 or greater.

Unlike urine drug testing, alcohol testing has very short detection windows, typically a few hours after consumption. The federal urine protocol does not apply to alcohol testing, but collection procedures follow strict chain of custody and device calibration requirements.

Is hair testing used in DOT drug testing?

Hair drug testing is not permitted for DOT-regulated safety-sensitive testing under the current federal regulations. However, some employers use hair drug tests for non-DOT roles because hair samples provide a longer detection window, up to 90 days, for substances like marijuana, cocaine, opiates, amphetamines, and PCP.

Hair testing requires different collection and laboratory protocols than urine tests. It cannot replace urine-based DOT testing but may complement it for broader screening in non-regulated positions.

AMH Nationwide facilitates hair testing through our national lab networks for clients who require extended detection periods outside DOT compliance.

What expanded drug panels are available beyond the standard DOT tests?

While DOT mandates testing for five specific drug classes, some employers opt for expanded panels that include additional substances such as benzodiazepines, barbiturates, MDMA (ecstasy), synthetic cannabinoids, and oxycodone derivatives.

These expanded panels are not DOT compliant for safety-sensitive testing but may be requested for comprehensive screening in non-DOT roles or for internal policy reasons.

AMH Nationwide coordinates expanded testing through our network labs, which use validated methods to detect these additional drugs with appropriate cutoff values and confirmatory techniques.

How do DOT testing requirements apply to reasonable suspicion and post-accident testing?

Reasonable suspicion and post-accident testing use the same urine drug and breath alcohol test types as pre-employment or random testing but are triggered by specific events or observations.

For reasonable suspicion, trained supervisors must document behavior indicative of impairment to justify testing. Post-accident testing applies when an incident meets criteria such as injury or property damage.

All collections follow the federally certified urine protocol and use NHTSA-approved breath alcohol devices. Results undergo review by a certified Medical Review Officer (MRO) before reporting.

What tests are required for return-to-duty and follow-up under DOT regulations?

Return-to-duty testing occurs after an employee has completed a substance abuse treatment program and must test negative on a DOT urine drug test and breath alcohol test before returning to safety-sensitive functions.

Follow-up testing involves unannounced, periodic urine and breath testing for a minimum of six tests in the first 12 months post-return, with the schedule determined by a substance abuse professional (SAP).

Both test types follow the same federally certified procedures and cutoff levels as other DOT testing to ensure ongoing compliance.

How to select the appropriate DOT drug and alcohol tests?

Selecting the correct DOT drug and alcohol test depends on the regulatory requirement, employment status, and reason for testing. The five-panel urine drug test remains the mandatory standard for safety-sensitive employees, while breath testing is the exclusive alcohol test accepted.

Employers should ensure testing providers follow 49 CFR Part 40 protocols and use certified MROs to review non-negative results. AMH Nationwide routes collections through five national lab networks, including Quest Diagnostics, LabCorp, Omega Labs, United States Drug Testing Labs, and ExperTox, to maintain compliance and quality.

Contact AMH Nationwide at (877) 731-6362 to discuss your DOT testing needs and receive guidance on panel selection and scheduling.

Common Questions